LESI | Print Page | Sign In | Join
Share |

LES 2013 Spring Meeting

Meeting Home | Schedule | Featured Speakers | Continuing Education | Presentations | On-Demand Recordings

Detailed Schedule


1:00 PM - 5:00 PM

2013 LES Foundation Graduate Student Business Plan Competition

Join us as student teams from across the globe present their cutting-edge, IP-based business plans to a world-class panel of judges in hopes of taking home valuable cash and in-kind prizes. We invite you to attend the final round of the 2013 LES Foundation Graduate Student Business Plan Competition.


8:00 AM - 7:00 PM


8:30 AM - 5:00 PM

IP & Licensing Basics - Sold Out

This course provides a survey of the basics of intellectual property (IP) and licensing. It builds a practical understanding of core IP and licensing concepts from both the business and legal perspectives. Each course, taught by both legal and business experts working as a team, is divided into five topics with examples, exercises and interaction between instructors and fellow students. Topics include: Introduction to IP; Basics of IP Commercialization & Licensing; Determining Reasonable License Fees & Royalty; Managing Risks; and a Licensing Case Study.

Ron Epperson, Managing Director, Intellectual Energy LLC
Michael Samardzija, Partner, Bracewell & Giuliani LLP

2:00 PM - 5:00 PM

As an additional benefit to our Spring Meeting attendees, LES is offering two free education workshops and an “Ask the Experts” open session, featuring an opportunity to discuss your questions directly with a panel of experienced industry leaders.


Case Study: Winning Negotiations through Practice

2:00 PM - 5:00 PM

Ask the Experts Session
(Open office hours)

"Ask the Experts" is an interactive, open-format session designed for all meeting attendees, but especially those that are new to the licensing business. During this session, attendees will have unparalleled access to top experts in the industry. They'll have a unique opportunity to seek advice and learn from these experts in both small group discussions and one-on-one consultations. 

6:00 PM - 7:30 PM

Welcome Reception


8:00 AM - 5:00 PM


8:30 AM - 9:15 AM

Continental Breakfast

9:15 AM - 10:30 AM


Solving the World's Imminent Problems with Innovative Science
The Bill & Melinda Gates Foundation, the Allen Institute for Brain Science, and the Infectious Disease Research Institute are all Seattle-based non-profit organizations that fund, manage and engage in life sciences research. Together and individually they represent organizations that make investments in basic science, clinical trials and seeing new products brought to market ultimately. Necessarily, intellectual property and licensing play a role in forming the collaborations and managing the work of these organizations.

The goal of this plenary session is to explain the work of these organizations, their overall objectives and the role that licensing plays. And given that they are all non-profit entities, the panel will explore the implications of licensing involving commercial actors to achieve charitable outcomes.

Chris Rivera, President, WBBA

Erik Iverson, Executive Vice President of Business Development and External Affairs, Infectious Disease Research Institute
Maja Larson, General Counsel, Allen Institute for Brain Science
Richard Wilder, Associate General Counsel, Bill & Melinda Gates Foundation

10:30 AM - 11:00 AM


Sponsored by:

11:00 AM - 12:00 PM


Secondary Patent Market - Trends and Practices

Recent large-scale and high-profile patent transactions have brought the marketplace into sharper focus for businesses, government, and the general public, making it apparent that the IP marketplace, along with its trends and practices, is an increasingly-important aspect of business. This distinguished panel of top dealmakers will share diverse perspectives on patent acquisitions and sales.They'll discuss the state of the secondary market and trends, share best practices, and aim to demystify the patent bubble.

Matt Penarczyk, Associate General Counsel, Microsoft

Michele Baumgartner-Bonanno, Director of IP Strategy, IBM
John Goldstone, Director, Technology Licensing, Weyerhaeuser
Jeremy Salesin, Vice President, Acquisitions, Intellectual Ventures

12:00 PM - 2:00 PM


IP Perspectives from a Northwest Angel Investor

Former Microsoft executive turned angel investor in clean tech Brian Arbogast will discuss IP relevance and challenges in the startup world. Brian, an angel investor and advisor, has a background in software strategy, development, and clean tech, and is on the boards of several local startups focused on innovative sustainability. He will discuss trends in impact investing, including business practices for sustainability.


Brian Arbogast, Senior Advisor, The Boston Consulting Group and Board Member & Angel Investor, Northwest Energy Angels

2:00 PM - 3:15 PM


Getting To Know the Federal and National Laboratories
The panel will discuss everything you ever wanted to know about the federal laboratories, but were afraid to ask. What is a federal lab? What goes on at a federal lab? What is the difference between a “national” and “federal” laboratory?

At a time when our economic future increasingly relies on scientific and engineering expertise, the federal and national laboratories provide critically important know-how and highly specialized facilities. The national and federal laboratories offer productive science, technology and engineering laboratories that provide knowledge and technology for the nation’s benefit.

There are over 300 federal laboratories and centers that provide cutting edge research and solutions. Going beyond their national missions, the laboratories work hand in hand with states, industry and universities to collaboratively solve local problems and pursue new research initiatives. The labs remain a largely untapped resource. Given their many contributions, it is to our advantage to partner and benefit from their knowledge and expertise.

Daniel Broderick, Jet Propulsion Laboratory & California Institute of Technology
Cheryl Cejka, Pacific Northwest National Laboratory
Robin Johnston, Joint Bioenergy Institute & Lawrence Berkeley National Laboratory
Annemarie Meike, Business Development Executive, Lawrence Livermore National Laboratory

Start-Ups Using IP to Break New Ground in Mobile Advertising, Marketing and Content Consumption

Simmone Misra, Senior Licensing Executive, Microsoft

Ivan Braiker, hipcricket, Augme Technologies
Isaac Jacobson, Accelerate Ventures
Laura Marriott, NeoMedia Technologies, Inc.
Mikko Välimäki, Tuxera 

Deflated in Canada - A Cautionary Tale of the Recent Viagra Ruling
In November of 2012, the Canadian Supreme Court unanimously decided to strike down Pfizer's patent on Viagra due to insufficient disclosure. The court found that Pfizer did not sufficiently disclose the exact compound that was effective in treating erectile disfunction, sildenafil, among a list of 260 quintillion chemical compounds named in the patent; the court also found that Pfizer knew that sildenafil was the effective compound at the time it filed the application but chose not to disclose it expressly (essentially gaming the patent system by playing “hide and seek” with the identification of the one effective compound, by hiding it among other ineffective ones). Is this just a quirky Canadian ruling? Or will lack of clear disclosure become an important issue in other pharma patents or in other jurisdictions? This court decision threw open the Canadian market for generic erectile disfunction drugs and forced Pfizer Canada to drop the Canadian price of Viagra immediately to bring it in line with generic versions. A related development was a class action lawsuit filed in December of 2012 in the Supreme Court of British Columbia on behalf of all purchasers of Viagra in British Columbia up to November, 2012, alleging that Pfizer unlawfully abused the patent system to obtain exclusive monopoly rights in Canada to sell Viagra and seeking to recover the overcharge that class members paid for Viagra up to the end of November, 2012. Could this happen in other jurisdictions? Panelists, which include Canadian, U.S. and European patent attorneys, will review the Canadian case and examine impacts in other jurisdictions, weaving a cautionary tale for those who draft and perform due diligence on pharmaceutical claims.

Sean Alexander, Gowling Lafleur Henderson LLP
Mae Joanne Rosok, Seed Intellectual Property Law Group PLLC
Hilton W.C. Sue, Oyen Wiggs Green & Mutala LLP
David H. Takagawa, Oyen Wiggs Green & Mutala LLP

3:15 PM - 3:45 PM


Sponsored by:

3:45 PM - 5:00 PM


East Meets West - Finding Common Ground for Successful IP Collaborations in China
Attracted by enormous market potential and relatively inexpensive labor, American companies flocked to China over the past 15 years despite deep concerns over what may become of their IP. Foreign players have begun to navigate the channels for obtaining and enforcing IP through what was once an untested PRC framework. It's now becoming clear that cooperation and rather than opposition is the touchstone for successful operations in China. This session explores where and how to find the common ground to build a foundation for success. The session will highlight the commonalities between U.S. and Chinese IP systems from the procurement and enforcement side, describe the IP challenges and successes of at least two high tech companies doing business in China and provide a perspective of how to turn adversaries into advocates with regard to IP.

Susan Pan, Sughrue Mion, PLLC
Shengping Yang, Beyond Law
Song Zhu, Hogan Lovells LLP

ePayments: Mobile Payments Demystified!
The mobile payments ecosystem is become more complex. The number of vendors and solutions are increasing daily.  Mobility now plays an important role in the shopping experience and the rise of the mobile phone as a payments tool seems unstoppable.

This session will help you understand the mobile payments ecosystem, the players, the benefits to consumers and merchants and the challenges it will present.

Scott Forbes, Intellectual Ventures
Jerry Gnuschke, HTC
Andy Kleitsch, Buck (Formerly Billing Revolution)
Lori Salow Marshall, BYNDL Inc.
Ashok Misra, Flint Mobile
Kelly Ogilvie, Quemulus, Inc.

De-Franchise My License Please!
Franchising and licensing are closely related concepts. Learn how to blend franchising and trademark and retail licensing. How T-Mobile, Starbucks and other innovative licensors have used franchising or licensing, and have avoided franchise laws or complied with franchise laws.

Gary Duvall, Dorsey & Whitney
Ed Miller, Starbucks Coffee Company
Michael J. Sentowski, T-Mobile

6:30 PM - 8:30 PM

Networking Reception at Chihuly Garden and Glass

Sponsored by:
Intellectual Ventures


8:00 AM - 12:00 PM


8:30 AM - 9:15 AM

Continental Breakfast

8:30 AM - 9:30 AM

Valuation & Taxation Committee Meeting
Great Room, Second Floor
Enjoy a continental breakfast and meet with other members of the committee to find out about upcoming events and all that’s new!

9:15 AM - 10:30 AM


Hello Kitty as a Global Licensing & Marketing Phenomenon
Sanrio is Japan's leading company in global licensing with products available in over 109 countries. Sanrio's success has been drawing a lot of attention, so much so that it was featured in a special documentary aired in May of 2012 by Japanese public broadcaster NHK. A key figure involved in this success is Ray Hatoyama, who took the company's Hello Kitty brand worldwide, and he will speak about his experiences. His talk will cover themes such as Sanrio's focus on globalizing its business in recent years, the localization of its operations worldwide, and the strong growth in global licensing.

Ray HatoyamaManaging Director, Strategy and Overseas Division, Sanrio

10:30 AM - 11:00 AM


Sponsored by:
Betts Patterson Mines

11:00 AM - 12:00 PM


West Coast Software Giants Focus on IP
  • What's top of mind from an IP perspective for each company?
  • What types of deals does the team get involved in?
  • What are the typical IP-related hurdles to clear, and where are the biggest challenges and opportunities moving into the future?

Dana Rao, Vice President, IP and Litigation, Adobe
Matthew Sarboraria, Patent Counsel, Oracle
Nissa Strottman, Senior Counsel, Cloud Computing and Open Source, HP

Life Sciences: A Guide to Turning a Strategic Partnership into an Acquisition
  • Commercializing your platform via strategic partnerships, while retaining enough proprietary to interest a would-be acquirer
  • How to identify appropriate strategic partners
  • When and how to call it quits on an unworkable strategic partnership
  • What terms in a strategic partnership agreement cause the most trouble when a strategic partnership is unwound
  • What do venture investors look for in strategic partnership deals
  • Negotiating terms that pave the way for a successful transition from strategic partnership to acquisition

Beth G. Etscheid, Director of Licensing, Washington Research Foundation

Eric Dobmeier, Chief Operating Officer, Seattle Genetics
Sonya Erickson, Partner, Cooley Godward
Kenneth Galbraith, General Partner, Ventures West Capital 
Jonathan Mow, Chief Business Officer, PhaseBio

12:00 PM - 1:30 PM



Geek's Guide to Seattle - Regional Innovation and Trends in the Tech Industry
What's unique about the Seattle region's technology industry, and what does its future say about the direction of the broader industry? Todd Bishop, a longtime technology journalist based in Seattle, will share inside secrets about the region's biggest players and look ahead to what's next — from airplanes and coffee to software and spaceflight.

Todd Bishop, Co-Founder, GeekWire

2:00 PM - 3:15 PM


IP Protection for Start-Ups: Is It Worth It?
While comprehensive international patent protection sounds attractive, it can be severely cost-prohibitive. This panel will discuss a pragmatic approach to intellectual property protection for small companies, with a particular focus on technology transfer from research organizations.

Andrea Belz, USC Greif Center for Entrepreneurial Studies
Rob Berman, CopyTele, Inc.
Dan Broderick, Caltech
Keith Rosema, Intellectual Ventures

Innovation California Style: How are West Coast Companies Getting from Bench to Product?
What is the recipe to nurture novel, innovative ideas to bear fruit in a commercial product? Representatives from the academic, pharma and founder community address the role each can play in the early stages of taking intellectual property from an academic setting to a startup. The panel will address those initial issues a new innovator company faces in licensing in intellectual property assets and how best to leverage those assets in early stage development deals.

Hemmie Chang, Foley Hoag LLP
Robert Dunkle, OncoSynergy
Karin Immergluck, P.D.,UCSF Office of Innovation, Technology and Alliances
Neela Patel, AbbVie

Tiptoe through the Jackpots: An Insiders' Look at the IP in the Gaming Industry
Wager gaming has evolved to a very interesting place in its history. In the last four years, in most of the world, the industry's revenues have remained relatively flat. The primary opportunity for growth has been the expansion of wager-gaming into the internet – particularly in America – which is currently unlawful. This raises at least a couple of very interesting questions.

JP Cody, PhD, MultiMedia Games
Terry McMillin, International Game Technology (IGT)
Jas Purewal, Osborne Clarke
Kevin Spivak, Greenblum & Bernstein

3:15 PM - 3:45 PM


3:45 PM - 5:00 PM


Innovation Happens When Collaboration Agreements Work

Frank Curci, After Wynne LLP
Bill Elkington, Rockwell Collins
Bob Held, TeleCommunication Systems, Inc.
Rodger McKinley, Boeing
David Vaughan, The Boeing Company

Halo Case Study: Building A Cultural Touchstone

Christine Finch, 343 Industries
Matt Skelton, Microsoft

5:00 PM - 6:00 PM

Closing Reception

Sponsored by the Intellectual Property Section of the Washington State Bar Association


11130 Sunrise Valley Drive, Suite 350 Reston, VA 20191 Phone: 703-234-4058 Fax: 703-435-4390